EMA evaluates Pfizer application for use of vaccine as booster

EMA evaluates Pfizer application for use of vaccine as booster

The EMA advises that a booster shot is not an urgent requirement for people who are healthy and not immunocompromised. File picture: PA

The European Medicines Agency (AMA) is evaluating an application from Pfizer to use its vaccine as a booster for anyone over 16.

In Ireland, only immunocompromised people, including children, are in line for a third vaccine shot, following advice given to Government last week.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited